Jabby: GLP-1 Shot Tracker
By JEKA
Jabby: GLP-1 Shot Tracker is a mobile health utility for individuals on GLP-1 weight-loss medications to log injections, track side effects, and monitor weight trends on iOS.
The App DNA
What makes this app unique?
It removes the cognitive friction of manual spreadsheets and paper titration schedules for patients managing complex, long-term medication protocols.
For Individuals currently prescribed GLP-1 weight-loss medications who require a tool to manage dosing schedules, track side effects, and monitor weight trends.
What does it look like?
Key features
Records weekly injection date, dose, and site to track rotation and adherence
Logs symptoms like nausea or fatigue on a 1-5 severity scale to identify patterns
Built-in schedules for semaglutide, tirzepatide, and liraglutide showing common dose progression
In-app space for users to share progress and ask questions with others on GLP-1 medications
How much does it cost?
The app operates as a free, ad-free utility, likely serving as a top-of-funnel acquisition tool for the developer's broader telehealth and prescription business.
Velocity
Maintenance developmentperformanceopaqueShow more...
Jabby: GLP-1 Shot Tracker currently operates on a maintenance cadence, with only one release shipped in the last 45 days. The development trend is stable but limited to minor stability and performance improvements. The publisher provides opaque release notes, offering no insight into specific feature development or roadmap progress. The app remains in a maintenance state, focusing exclusively on technical upkeep rather than new content or functionality.
Who built it?
User Sentiment
What do users think recently?
Review voice lately leans frustrated. Users appreciate the simple design of the reminder and weight logging features provides a straightforward utility for users.
How are ratings & reviews evolving?
What users say, by theme
- The simple design of the reminder and weight logging features provides a straightforward utility for users
- The application fails to launch and remains frozen on the home screen for many users
8 of 8 recent reviews analyzed · limited sample · Frustrated overall
Read the full review analysisUnlock 1 more frustration theme, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Jabby: GLP-1 Shot Tracker
How's the Health & Fitness market?
Jabby: GLP-1 Shot Tracker occupies a niche utility space in the Health & Fitness category, currently maintaining a 4.26 rating across 69 total ratings. The lack of recent feature updates suggests a maintenance-mode posture that leaves the app vulnerable to more stable, general-purpose health trackers.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Jabby: GLP-1 Shot Tracker
Where is it heading?
Jabby: GLP-1 Shot Tracker faces a critical stability gap that threatens its role as a telehealth acquisition funnel. Unless the developer addresses the launch-freezing issue immediately, the app will lose its user base to more stable, general-purpose health trackers before the next major update cycle.
- The latest release remains plagued by launch-freezing bugs, which prevents users from accessing the core reminder and tracking features.
- Inability to adjust reminder schedules forces users to abandon the app, as the tool fails to accommodate individual medication routines.
The SWOT
- Titration guidance establishes clinical-adjacent utility
- Ad-free model lowers the barrier to entry
- Localized titration content for emerging GLP-1 markets
Next best moves
Rebuild launch sequence because freezing on the home screen is the #1 churn risk → restore daily active usage
+ 1 more prioritized moveThe counter-intuitive read
The app's lack of monetization is a strategic liability, not a feature…
Read the full takeBottom line
Jabby: GLP-1 Shot Tracker must resolve the launch-freezing bug to prevent total user abandonment, as the current instability negates the value of its titration guidance. Stabilizing the core utility is the only path to retaining the user base for the developer's telehealth funnel.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated